Breast Cancer and Prostaglandins: Effects on Survival
Author Information
Author(s): A. Bennett, I.F. Stamford, D.A. Berstock, F. Dische, L. Singh, R.P. A'Hern
Primary Institution: King's College School of Medicine and Dentistry
Hypothesis
What is the relationship between prostaglandin-like material in breast tumors and patient survival?
Conclusion
Higher levels of tumor prostaglandin-like material do not predict overall survival but are inversely correlated with early death in post-menopausal women.
Supporting Evidence
- Prostaglandin-like material levels were higher in tumors from post-menopausal women compared to premenopausal women.
- Intermediate levels of tumor prostaglandin-like material were associated with the longest disease-free survival.
- Patients with low levels of tumor prostaglandin-like material had no positive bone scans near the time of surgery.
Takeaway
This study looked at how a substance called prostaglandin in breast tumors affects how long patients live. It found that having too much or too little might not be good, but just the right amount could help patients live longer.
Methodology
The study analyzed 141 breast tumors from women undergoing surgery, measuring the levels of prostaglandin-like material and correlating it with various clinical outcomes.
Potential Biases
Potential biases in histological assessments and the retrospective nature of the study.
Limitations
The study had limitations in measuring and identifying the source of tumor prostaglandin-like material.
Participant Demographics
The study included 141 women with breast cancer, with a mix of premenopausal and postmenopausal patients.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website